Daniel K. Spiegelman, Director at MYRIAD GENETICS INC (MYGN), sold 15,152 shares at $22.04 ($334K) on 2024-06-03, disclosed to the SEC on 2024-06-04.
Scheduled sale ($334k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.04 | 3,788 | $83K | 25.0% |
| 2 | $22.04 | 3,788 | $83K | 25.0% |
| 3 | $22.05 | 3,788 | $84K | 25.0% |
| 4 | $22.05 | 3,788 | $84K | 25.0% |
| Total | $22.05 avg | 15,152 | $334K | 100% |
| Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |
| BMRN | SELL | 2019-04-03 | $1.2M | — | Filing → |